Published in Healthcare Mergers, Acquisitions and Ventures Week, February 3rd, 2007
"The fully human MAb (also referred to as MDX-1303 or Valortim) was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.